My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 137

    1.

    Adipokines and incident type 2 diabetes in an Aboriginal Canadian [corrected] population: the Sandy Lake Health and Diabetes Project.

    Ley SH, Harris SB, Connelly PW, Mamakeesick M, Gittelsohn J, Hegele RA, Retnakaran R, Zinman B, Hanley AJ.

    Diabetes Care. 2008 Jul;31(7):1410-5. Epub 2008 Mar 13. Erratum in: Diabetes Care. 2008 Aug;31(8):1713. PMID: 18339973 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Metabolic syndrome and its components as predictors of incident type 2 diabetes mellitus in an Aboriginal community.

    Ley SH, Harris SB, Mamakeesick M, Noon T, Fiddler E, Gittelsohn J, Wolever TM, Connelly PW, Hegele RA, Zinman B, Hanley AJ.

    CMAJ. 2009 Mar 17;180(6):617-24.PMID: 19289805 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Associations of adiponectin levels with incident impaired glucose metabolism and type 2 diabetes in older men and women: the hoorn study.

    Snijder MB, Heine RJ, Seidell JC, Bouter LM, Stehouwer CD, Nijpels G, Funahashi T, Matsuzawa Y, Shimomura I, Dekker JM.

    Diabetes Care. 2006 Nov;29(11):2498-503.PMID: 17065691 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Adipokines and risk of type 2 diabetes in older men.

    Wannamethee SG, Lowe GD, Rumley A, Cherry L, Whincup PH, Sattar N.

    Diabetes Care. 2007 May;30(5):1200-5. Epub 2007 Feb 23.PMID: 17322479 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    High plasma C-reactive protein (CRP) is related to low paraoxonase-I (PON-I) activity independently of high leptin and low adiponectin in type 2 diabetes mellitus.

    Dullaart RP, de Vries R, Sluiter WJ, Voorbij HA.

    Clin Endocrinol (Oxf). 2009 Feb;70(2):221-6.PMID: 18505467 [PubMed - indexed for MEDLINE]Related articles

    6.

    Adiponectin in a native Canadian population experiencing rapid epidemiological transition.

    Hanley AJ, Connelly PW, Harris SB, Zinman B.

    Diabetes Care. 2003 Dec;26(12):3219-25.PMID: 14633805 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Leptin and incident type 2 diabetes: risk or protection?

    Schmidt MI, Duncan BB, Vigo A, Pankow JS, Couper D, Ballantyne CM, Hoogeveen RC, Heiss G; ARIC Investigators.

    Diabetologia. 2006 Sep;49(9):2086-96. Epub 2006 Jul 19.PMID: 16850292 [PubMed - indexed for MEDLINE]Related articles

    8.

    Adipocytokines and incident diabetes mellitus in older adults: the independent effect of plasminogen activator inhibitor 1.

    Kanaya AM, Wassel Fyr C, Vittinghoff E, Harris TB, Park SW, Goodpaster BH, Tylavsky F, Cummings SR.

    Arch Intern Med. 2006 Feb 13;166(3):350-6.PMID: 16476877 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Lifestyle variables, non-traditional cardiovascular risk factors, and the metabolic syndrome in an Aboriginal Canadian population.

    Liu J, Young TK, Zinman B, Harris SB, Connelly PW, Hanley AJ.

    Obesity (Silver Spring). 2006 Mar;14(3):500-8.PMID: 16648622 [PubMed - indexed for MEDLINE]Related articles

    10.

    Adiponectin and C-reactive protein in obesity, type 2 diabetes, and monodrug therapy.

    Putz DM, Goldner WS, Bar RS, Haynes WG, Sivitz WI.

    Metabolism. 2004 Nov;53(11):1454-61.PMID: 15536601 [PubMed - indexed for MEDLINE]Related articles

    11.

    Serum CRP levels are equally elevated in newly diagnosed type 2 diabetes and impaired glucose tolerance and related to adiponectin levels and insulin sensitivity.

    Yuan G, Zhou L, Tang J, Yang Y, Gu W, Li F, Hong J, Gu Y, Li X, Ning G, Chen M.

    Diabetes Res Clin Pract. 2006 Jun;72(3):244-50. Epub 2005 Dec 27.PMID: 16377022 [PubMed - indexed for MEDLINE]Related articles

    12.

    Osteoprotegerin in relation to body weight, lipid parameters insulin sensitivity, adipocytokines, and C-reactive protein in obese and non-obese young individuals: results from both cross-sectional and interventional study.

    Gannagé-Yared MH, Yaghi C, Habre B, Khalife S, Noun R, Germanos-Haddad M, Trak-Smayra V.

    Eur J Endocrinol. 2008 Mar;158(3):353-9.PMID: 18299469 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Features of the metabolic syndrome predict higher risk of diabetes and impaired glucose tolerance: a prospective study in Mauritius.

    Boyko EJ, de Courten M, Zimmet PZ, Chitson P, Tuomilehto J, Alberti KG.

    Diabetes Care. 2000 Sep;23(9):1242-8.PMID: 10977013 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Urinary albumin excretion and its relation with C-reactive protein and the metabolic syndrome in the prediction of type 2 diabetes.

    Brantsma AH, Bakker SJ, Hillege HL, de Zeeuw D, de Jong PE, Gansevoort RT; PREVEND Study Group.

    Diabetes Care. 2005 Oct;28(10):2525-30.PMID: 16186291 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and [corrected] hypoadiponectinemia.

    Samaras K, Wand H, Law M, Emery S, Cooper D, Carr A.

    Diabetes Care. 2007 Jan;30(1):113-9. Erratum in: Diabetes Care. 2007 Feb;30(2):455. PMID: 17192343 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    [Prevalence of type II diabetes mellitus in population of Krakow]

    Szurkowska M, Szybiński Z, Nazim A, Szafraniec K, Jedrychowski W.

    Pol Arch Med Wewn. 2001 Sep;106(3):771-9. Polish. PMID: 11928585 [PubMed - indexed for MEDLINE]Related articles

    17.

    Adipokines, insulin resistance, and coronary artery calcification.

    Qasim A, Mehta NN, Tadesse MG, Wolfe ML, Rhodes T, Girman C, Reilly MP.

    J Am Coll Cardiol. 2008 Jul 15;52(3):231-6.PMID: 18617073 [PubMed - indexed for MEDLINE]Related articles

    18.

    Serum adiponectin concentrations predict the developments of type 2 diabetes and the metabolic syndrome in elderly Koreans.

    Choi KM, Lee J, Lee KW, Seo JA, Oh JH, Kim SG, Kim NH, Choi DS, Baik SH.

    Clin Endocrinol (Oxf). 2004 Jul;61(1):75-80.PMID: 15212647 [PubMed - indexed for MEDLINE]Related articles

    19.

    Elevations in markers of liver injury and risk of type 2 diabetes: the insulin resistance atherosclerosis study.

    Hanley AJ, Williams K, Festa A, Wagenknecht LE, D'Agostino RB Jr, Kempf J, Zinman B, Haffner SM; insulin resistance atherosclerosis study.

    Diabetes. 2004 Oct;53(10):2623-32.PMID: 15448093 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population: The Hoorn Study.

    de Vegt F, Dekker JM, Jager A, Hienkens E, Kostense PJ, Stehouwer CD, Nijpels G, Bouter LM, Heine RJ.

    JAMA. 2001 Apr 25;285(16):2109-13.PMID: 11311100 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity